Bradley Hardiman
Private Equity Investor bei Cambridge Enterprise Ltd.
Profil
Mr. Bradley Hardiman is an Investment Manager (Life Sciences) at Cambridge Enterprise Ltd.
and a Director & Investor Director at Fluidic Analytics Ltd.
He is on the Board of Directors at Definigen Ltd.
and Fluidic Analytics Ltd.
He received his undergraduate degree from Brunel University, a graduate degree from the University of Cambridge, and an MBA from Cass Business School.
Aktive Positionen von Bradley Hardiman
Unternehmen | Position | Beginn |
---|---|---|
Cambridge Enterprise Ltd.
Cambridge Enterprise Ltd. Investment ManagersFinance Cambridge Enterprise Ltd.(CEL) is a Venture Capital firm, a subsidiary of University of Cambridge founded in 1972. Headquartered in Cambridge. | Private Equity Investor | 01.03.2010 |
Ehemalige bekannte Positionen von Bradley Hardiman
Unternehmen | Position | Ende |
---|---|---|
Fluidic Analytics Ltd.
Fluidic Analytics Ltd. BiotechnologyHealth Technology Fluidic Analytics Ltd. develops proprietary technology to characterize proteins. The company was founded by Tuomas Knowles in 2013 and is headquartered in Cambridge, the United Kingdom. | Direktor/Vorstandsmitglied | - |
CAMBfix Ltd.
CAMBfix Ltd. Medical/Nursing ServicesHealth Services CAMBfix Ltd. provides trauma fixation system. It offers cambfix range, such as bajwa non-invasive wrist fixator, bajwa non-invasive self de-tensioning wrist fixator, and novel cast lining material; and product pipeline, such as non-invasive ankle fixator, non-invasive tibial fixator, and non-invasive elbow fixator. The company was founded by Linda Christine Pomeroy and Ali S. Bajwa in 2004 and is headquartered in Tyne and Wear, the United Kingdom. | Direktor/Vorstandsmitglied | - |
DefiniGEN Ltd.
DefiniGEN Ltd. Miscellaneous Commercial ServicesCommercial Services DefiniGEN Ltd. provides human cell products to the drug discovery sector. Its services include iPSC Differentiation, Gene Editing, CRISPR Modeling and Patient Derived Models. The firm products include Hepatocytes, Intestinal and Pancreatic. The company was founded in April 2012 by Candy Hsin-Hua Cho, Nicolas R. F. Hannan, Roger A. Pedersen and Tamir Rashid and is headquartered in Cambridge, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Ausbildung von Bradley Hardiman
Brunel University | Undergraduate Degree |
University of Cambridge | Graduate Degree |
Bayes Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
Cambridge Enterprise Ltd.
Cambridge Enterprise Ltd. Investment ManagersFinance Cambridge Enterprise Ltd.(CEL) is a Venture Capital firm, a subsidiary of University of Cambridge founded in 1972. Headquartered in Cambridge. | Finance |
CAMBfix Ltd.
CAMBfix Ltd. Medical/Nursing ServicesHealth Services CAMBfix Ltd. provides trauma fixation system. It offers cambfix range, such as bajwa non-invasive wrist fixator, bajwa non-invasive self de-tensioning wrist fixator, and novel cast lining material; and product pipeline, such as non-invasive ankle fixator, non-invasive tibial fixator, and non-invasive elbow fixator. The company was founded by Linda Christine Pomeroy and Ali S. Bajwa in 2004 and is headquartered in Tyne and Wear, the United Kingdom. | Health Services |
DefiniGEN Ltd.
DefiniGEN Ltd. Miscellaneous Commercial ServicesCommercial Services DefiniGEN Ltd. provides human cell products to the drug discovery sector. Its services include iPSC Differentiation, Gene Editing, CRISPR Modeling and Patient Derived Models. The firm products include Hepatocytes, Intestinal and Pancreatic. The company was founded in April 2012 by Candy Hsin-Hua Cho, Nicolas R. F. Hannan, Roger A. Pedersen and Tamir Rashid and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
Fluidic Analytics Ltd.
Fluidic Analytics Ltd. BiotechnologyHealth Technology Fluidic Analytics Ltd. develops proprietary technology to characterize proteins. The company was founded by Tuomas Knowles in 2013 and is headquartered in Cambridge, the United Kingdom. | Health Technology |